Brendan T. Finicle - Concepedia

Author

Brendan T. Finicle

University of California, Irvine ORCID

Also Known As

Brendan T Finicle, Brendan T. Finicle, Brendan T Finicle, Finicle, Brendan T.

Publications

648

Citations

H-Index

Concepts

All Affiliations

University of California, Irvine Université de Montréal

About

Brendan T. Finicle is an author at University of California, Irvine specializing in medicine, natural sciences, and cellular biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	129
2	Natural Sciences	4	4	129
3	Biochemistry	3	3	107
4	Cell Biology	3	3	119
5	Biomolecular Engineering	1	1	22

Brendan T. Finicle

Publications

351

Citations

H-Index

Page 1

	Year	Citations
PTEN Deficiency and AMPK Activation Promote Nutrient Scavenging and Anabolism in Prostate Cancer Cells Seong Min Kim, Tricia T Nguyen, Archna Ravi, Cancer Discovery	2018	194
Targeting cancer metabolism by simultaneously disrupting parallel nutrient access pathways Seong Min Kim, Saurabh G. Roy, Bin Chen, Journal of Clinical Investigation Chemoprevention StrategyMetabolic RemodelingCancer BiologyTumor BiologyOncogenic Mutations	2016	76
Simultaneous inhibition of endocytic recycling and lysosomal fusion sensitizes cells and tissues to oligonucleotide therapeutics Brendan T. Finicle, Kazumi Eckenstein, Alexey S. Revenko, Nucleic Acids Research Molecular BiologyOligonucleotide TherapeuticsOligonucleotide ActivityEndocytic PathwayAntisense Therapy	2023	22
Sphingolipids inhibit endosomal recycling of nutrient transporters by inactivating ARF6 Brendan T. Finicle, Manuel U. Ramirez, Gang Liu, Journal of Cell Science Endogenous SphingolipidsCell DeathLipid MovementCellular PhysiologyArf6 Inactivation	2018	21
Dynamic Phosphoproteomics Uncovers Signaling Pathways Modulated by Anti-oncogenic Sphingolipid Analogs Peter Kubiniok, Brendan T. Finicle, Fanny Piffaretti, Molecular & Cellular Proteomics	2018	15
Synthetic Sphingolipids with 1,2-Pyridazine Appendages Improve Antiproliferative Activity in Human Cancer Cell Lines Sylvestre P. J. T. Bachollet, Vito Vece, Alison N. McCracken, ACS Medicinal Chemistry Letters	2020	13
Design, synthesis and anticancer activity of constrained sphingolipid-phenoxazine/phenothiazine hybrid constructs targeting protein phosphatase 2A Jean-Baptiste Garsi, Vito Vece, Lorenzo Sernissi, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryDrug TargetingBiochemistryNatural Sciences	2019	10

Page 1